Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Bunick

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
JAAD International|August 20, 2025
When topicals fall short, oral Janus kinase inhibitors offer a needed solution in chronic hand eczemaChristopher G Bunick
The Journal of Investigative Dermatology|November 11, 2014
Perspectives on physiology and medicine from Nobel Prize Winners: the 64th Lindau Nobel Laureate MeetingChristopher G Bunick
The Journal of Investigative Dermatology|August 6, 2025
Biologic Therapies Targeting Type 2 Signaling in Atopic Dermatitis: A Comparative Review of Structural and Thermodynamic Differences in Mechanism of ActionChristopher G Bunick
The Journal of Investigative Dermatology|May 27, 2025
Revisiting RORγt Inhibition in Plaque Psoriasis: Lessons Learned from BI 730357Hossein Akbarialiabad, Christopher G Bunick
Cutis|January 26, 2026
Path of Least Resistance: Guidance for Antibiotic Stewardship in AcneAyman Grada, Christopher G Bunick
Dermatology and Therapy|December 5, 2025
Empathy for the Patient with Chronic Hand EczemaMonique Tooks, Christopher G Bunick
Clinical, Cosmetic and Investigational Dermatology|September 18, 2023
Congenital Ichthyosis: A Practical Clinical Guide on Current Treatments and Future PerspectivesEvelyn Lilly, Christopher G Bunick
The Journal of Investigative Dermatology|April 28, 2023
Demystifying Hand EczemaAyman Grada, Christopher G Bunick
The Journal of Investigative Dermatology|August 18, 2025
Structural basis for differential JAK2 and JAK3 kinase selectivity of ruxolitinib and delgocitinibJimin Wang, Christopher G Bunick
JAMA Network Open|April 29, 2021
Spectrum of Antibiotic Activity and Its Relevance to the MicrobiomeAyman Grada, Christopher G Bunick
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
JAAD International|August 20, 2025
When topicals fall short, oral Janus kinase inhibitors offer a needed solution in chronic hand eczemaChristopher G Bunick
The Journal of Investigative Dermatology|November 11, 2014
Perspectives on physiology and medicine from Nobel Prize Winners: the 64th Lindau Nobel Laureate MeetingChristopher G Bunick
The Journal of Investigative Dermatology|August 6, 2025
Biologic Therapies Targeting Type 2 Signaling in Atopic Dermatitis: A Comparative Review of Structural and Thermodynamic Differences in Mechanism of ActionChristopher G Bunick
The Journal of Investigative Dermatology|May 27, 2025
Revisiting RORγt Inhibition in Plaque Psoriasis: Lessons Learned from BI 730357Hossein Akbarialiabad, Christopher G Bunick
Cutis|January 26, 2026
Path of Least Resistance: Guidance for Antibiotic Stewardship in AcneAyman Grada, Christopher G Bunick
Dermatology and Therapy|December 5, 2025
Empathy for the Patient with Chronic Hand EczemaMonique Tooks, Christopher G Bunick
Clinical, Cosmetic and Investigational Dermatology|September 18, 2023
Congenital Ichthyosis: A Practical Clinical Guide on Current Treatments and Future PerspectivesEvelyn Lilly, Christopher G Bunick
The Journal of Investigative Dermatology|April 28, 2023
Demystifying Hand EczemaAyman Grada, Christopher G Bunick
The Journal of Investigative Dermatology|August 18, 2025
Structural basis for differential JAK2 and JAK3 kinase selectivity of ruxolitinib and delgocitinibJimin Wang, Christopher G Bunick
JAMA Network Open|April 29, 2021
Spectrum of Antibiotic Activity and Its Relevance to the MicrobiomeAyman Grada, Christopher G Bunick
Pageof 16